South Carolina reports 99 new measles cases; now more than 300 cases in Upstate outbreak
On Jan. 12, 2026, a measles outbreak in South Carolina continues to grow, and now neighboring North Carolina is…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
Phage G genome: AI analysis maps out world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
Ypsomed to establish first U.S. manufacturing facility in North Carolina
On Oct. 10, 2025, Ypsomed announced it will establish its first manufacturing facility in the United States. The…
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
On Sept. 4, 2025, Revvity announced the opening of its new In Vivo Imaging Center of Excellence in…
Duke Receives $69 Million NIH Grant to Translate Science into Better Health for All
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
On Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…
Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
On Aug. 7, 2025, The first paper from a multi-year clinical research study has been published in The…
Mars Partners with Pairwise to Accelerate Cacao Research Using CRISPR platform
On Aug. 6, Mars has licensed Pairwise’s Fulcrum® gene editing tools for cacao research and development. This licensing…
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park
On Jul. 21, 2025, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing…
New Technique Could Increase Infant Heart Transplant by 20%
On Jul. 16, 2025, Duke Health has pioneered a world’s-first technique that could expand by up to 20%…
Researchers Hit ‘Fast Forward’ on Materials Discovery with Self-Driving Labs
On Jul. 14, 2025, researchers from North Carolina State University (NCSU) have demonstrated a new technique that allows…
First Case of Measles Identified in North Carolina
On Jun. 24, 2025, the North Carolina Department of Health and Human Services has confirmed a case of…
Deadly listeria outbreak linked to chicken alfredo fettucine sold at Kroger and Walmart
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
Genentech boosts U.S. presence with new $700 million North Carolina facility
On May 12, 2025, Genentech announced plans to invest more than $700 million in a new 700,000 square…
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
Ligand Acquires Assets of Novan for $12.2 Million
On Sep. 27, 2023, Ligand Pharmaceuticals announced that it has closed the transaction to acquire assets of Novan following…
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
Chimerix announced FDA acceptance of NDA for brincidofovir as a medical countermeasure for smallpox
On Dec. 7, 2020, Chimerix announced the U.S. Food and Drug Administration (FDA) had accepted the filing of a…
Biotechnology | CDC | Infectious Disease | Influenza | NIH | Therapeutics
U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National Stockpile
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
Disease | NIH | Therapeutics
NIAID awarded BioCryst $44 million contract to advance development of galidesivir
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
Chimerix received FDA clearance for rolling submission of New Drug Application for brincidofovir as medical countermeasure for smallpox
On Apr. 28, 2020, Chimerix announced it had received clearance from the FDA for a rolling submission of…
Albert Einstein College of Medicine invented compound tested in COVID-19 clinical trial
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
BioCryst began clinical trial with Galidesivir for treatment of patients with COVID-19
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
On Nov. 15, 2019, Amgen in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate…